---
title: The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment
  of Cancer-Induced Lymphatic Metastasis and Lymphangiosarcoma
date: '2025-01-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39791369/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250110170846&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: These findings suggest that targeting SOX18 with Sm4 may
  hold potential as a therapeutic strategy for lymphangiosarcoma and cancer-induced
  lymphatic metastasis. Further in vitro studies are warranted to investigate the
  mechanisms and conduct dose-response analyses to evaluate Sm4''s potential as a
  targeted therapy for lymphangiosarcoma and cancer-induced lymphangiogenesis in the
  ...'
disable_comments: true
---
CONCLUSION: These findings suggest that targeting SOX18 with Sm4 may hold potential as a therapeutic strategy for lymphangiosarcoma and cancer-induced lymphatic metastasis. Further in vitro studies are warranted to investigate the mechanisms and conduct dose-response analyses to evaluate Sm4's potential as a targeted therapy for lymphangiosarcoma and cancer-induced lymphangiogenesis in the ...